PatientsVille.com LogoPatientsVille.com

Psoriasis | Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis

Psoriasis research study

What is the primary objective of this study?

The purpose of this study is to determine whether acupuncture is helpful for patients with joint pain associated with psoriasis

Who is eligible to participate?

Inclusion Criteria: - Plaque psoriasis - Pain from at least two peripheral joints and/or inflammatory back pain - No or stabile treatment of the psoriasis the last 3 months - No or stabile pain treatment the last 3 months - Oral and written information given - Written consent signed Exclusion Criteria: - Arthritis with Ultrasound verified intra articular fluid og clinical verified joint swelling - Pregnancy og breastfeeding - Previous treatments with acupuncture - Treatment with anticoagulants (vitamin K-antagonists, low molecular weight heparin, unfractionated heparin, direct thrombin inhibitors, direct factor Xa inhibitors) - Unwilling to follow protocol

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Psoriasis

Arthralgia

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:AcupuncturePatients are randomized to real acupuncture or sham acupuncture if they are in the intervention group

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Acupuncture in active pointsPatients in this group will receive real acupuncture

Acupuncture in non-active pointsPatients in this group will receive acupuncture, but in non-active points

No treatment, just observationPatients in this group will receive no treatment and will only be observed.

Study Status

Unknown status

Start Date: October 2014

Completed Date: December 2017

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Pain measured on the VAS

Secondary Outcome: Approvement in skin lesions

Study sponsors, principal investigator, and references

Principal Investigator:

Lead Sponsor: University Hospital, Gentofte, Copenhagen

Collaborator: Aage Bangs Fond

More information:https://clinicaltrials.gov/show/NCT02047851

Discuss Arthralgia